Award
NIH Reporter #5R01HD111549-04
Optimization of lead candidates for an on-demand male contraceptive
Recipient
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Award Amount
$687,095.00
Ceiling
$687,095.00
Awarded
June 09, 2026
Identifier
5R01HD111549-04
Award for research on developing male contraceptive drugs by optimizing sAC inhibitors for preclinical development and FDA IND application.
Description
This project involves the development of soluble adenylyl cyclase (sAC) inhibitors as a male contraceptive. The project aims to test potent, selective, non-toxic sAC inhibitors through in vitro and in vivo studies to identify candidates suitable for preclinical development and FDA IND application.